Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
12.24
-0.26 (-2.08%)
May 29, 2026, 12:15 PM EDT - Market open
Corvus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $30 | Buy | Reiterates | $30 | +145.10% | May 18, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $33 | Buy | Reiterates | $33 | +169.61% | May 15, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $40 | Buy | Maintains | $40 | +226.80% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $27 | Buy | Reiterates | $27 | +120.59% | May 15, 2026 |
| Barclays | Barclays | Buy Maintains $28 | Buy | Maintains | $28 | +128.76% | May 15, 2026 |
| Jefferies | Jefferies | Buy Maintains $13 → $42 | Buy | Maintains | $13 → $42 | +243.14% | Jan 22, 2026 |